1. Home
  2. LEE vs ATNM Comparison

LEE vs ATNM Comparison

Compare LEE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • ATNM
  • Stock Information
  • Founded
  • LEE 1890
  • ATNM 2000
  • Country
  • LEE United States
  • ATNM United States
  • Employees
  • LEE N/A
  • ATNM N/A
  • Industry
  • LEE Newspapers/Magazines
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • ATNM Health Care
  • Exchange
  • LEE Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • LEE 52.4M
  • ATNM 51.5M
  • IPO Year
  • LEE N/A
  • ATNM N/A
  • Fundamental
  • Price
  • LEE $6.17
  • ATNM $1.56
  • Analyst Decision
  • LEE
  • ATNM Strong Buy
  • Analyst Count
  • LEE 0
  • ATNM 3
  • Target Price
  • LEE N/A
  • ATNM $4.67
  • AVG Volume (30 Days)
  • LEE 14.9K
  • ATNM 229.8K
  • Earning Date
  • LEE 05-08-2025
  • ATNM 05-09-2025
  • Dividend Yield
  • LEE N/A
  • ATNM N/A
  • EPS Growth
  • LEE N/A
  • ATNM N/A
  • EPS
  • LEE N/A
  • ATNM N/A
  • Revenue
  • LEE $591,094,000.00
  • ATNM N/A
  • Revenue This Year
  • LEE N/A
  • ATNM N/A
  • Revenue Next Year
  • LEE N/A
  • ATNM N/A
  • P/E Ratio
  • LEE N/A
  • ATNM N/A
  • Revenue Growth
  • LEE N/A
  • ATNM N/A
  • 52 Week Low
  • LEE $6.15
  • ATNM $1.03
  • 52 Week High
  • LEE $19.63
  • ATNM $8.64
  • Technical
  • Relative Strength Index (RSI)
  • LEE 24.76
  • ATNM 51.11
  • Support Level
  • LEE $6.15
  • ATNM $1.51
  • Resistance Level
  • LEE $6.97
  • ATNM $1.69
  • Average True Range (ATR)
  • LEE 0.28
  • ATNM 0.11
  • MACD
  • LEE -0.06
  • ATNM -0.02
  • Stochastic Oscillator
  • LEE 1.48
  • ATNM 36.78

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: